ESMO 2026: Empowering Patients with Early Breast Cancer
/ Maria Alice Franzoi
ESMO 2026: Immune Profiling and Biomarkers in Stage III NSCLC
/ Elisabeth Müller
ESMO 2026: The Current and Future Role of Radiotherapy in SCLC
/ Bjørn Henning Grønberg
ESMO 2026: When Immune Organs Are Removed: The Impact on Cancer Risk
/ Ida Maria Hemdorff Eriksen
ESMO 2026: Assessing Response and Treatment Choice in Urothelial Cancer
/ Jørgen Bjerggaard Jensen
ESMO 2026: Adjuvant Cemiplimab in High-Risk CSCC
/ Vishal Anil Patel











